Terns Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $497k | 60k | 8.34 |
| 2024-06-30 | $1.0M | 153k | 6.81 |
| 2024-03-31 | $2.8M | 422k | 6.56 |
| 2023-12-31 | $1.4M | 218k | 6.49 |
| 2023-09-30 | $1.4M | 283k | 5.03 |
| 2023-06-30 | $3.3M | 382k | 8.75 |
| 2023-03-31 | $7.7M | 632k | 12.26 |
| 2022-12-31 | $12M | 1.2M | 9.76 |
| 2022-06-30 | $2.0k | 963 | 2.08 |
| 2022-03-31 | $28k | 9.4k | 2.95 |
| 2021-12-31 | $52k | 7.4k | 7.04 |
| 2021-03-31 | $519k | 24k | 22.05 |